Group Action Lawyers
Latest News & Updates

Category: Medical

alert
December 24, 2016
Healthcare apps pose health and data protection risks

With all this technology, you’d have thought that apps were advanced enough to detect health dangers. However, this unfortunately may not be the case for many smartphone health apps.

We as Group Action Lawyers represent victims for Medical Group Actions and Data Breach Group Actions, so this is right up our avenue of experience.
Continue Reading…

unborn babies at risk
December 23, 2016
Sanofi Depakote epilepsy drug that reportedly caused birth defects in 10,000 unborn babies

Valproate Semisodium, better known as Depakote, has reportedly put more than 10,000 pregnant women at risk in France, and there are raising concerns that the same amount of women in the U.K. may also be affected by the epilepsy drug.

Our Group Action Lawyers are investigating the issues, and anyone affected here in the U.K. is free to come forward for confidential and no obligation advice.
Continue Reading…

December 22, 2016
Updated advice on the recent Stockert 3T heater-cooler issues

The Stockert 3T heater-coolers used during certain surgeries have been linked to a dangerous microorganism, Mycobacterium chimaera.

The manufacturers of the ‘deadly device’ have now issued advice in relation to managing and cleaning the device as part of ongoing investigations.
Continue Reading…

December 20, 2016
In recent years, there have been deaths allegedly linked to the use of Medtronic infusion pumps

Since its introduction into the market, the Medtronic infusion pump has been apparently overwhelmed with problems.

In recent years, problems that have been linked to the use of the pumps have reportedly caused dozens of deaths. As such, health authorities and the manufactures are in the process of taking appropriate action, and we’ll be looking in to whether there is any negligence here.
Continue Reading…

December 13, 2016
Sandwell and West Birmingham NHS Pelvic Floor Prolapse recall – we’re still taking cases forward

Birmingham surgeon Dr. Angamuthu Arunkalaivanan performed hundreds of the pelvic floor surgeries using a mesh implant that the Trust he worked for had banned from using.

Dr. Arunkalaivanan seemingly ignored the Trust’s instructions and carried on inserting these mesh implants into hundreds of women despite the warnings from the National Institute for Health and Care Excellence (NICE) of incontinence and infection, and his own Trust’s policy on their use.

Some 200 patients who have undergone pelvic floor surgeries with Dr. Arunkalaivanan have been recalled to be checked. However, pelvic floor operations are so routine that it may be many more than 200 woman affected by the surgeons actions.
Continue Reading…

November 30, 2016
Xarelto drug reportedly causing internal bleeding and one death a week

A stern warning for all patients prescribed the blood-thinning drug Rivaroxaban; sold under the name of Xarelto, that’s available on the NHS:

Reports suggest that it’s causing one death a week from internal bleeding, which is extremely alarming. The German manufacturer of the product, Bayer, are currently facing legal actions from around the world.

Continue Reading…

November 28, 2016
“Medical device battery fault that have caused two deaths” – Battery defects of the implantable cardioverter defibrillators and cardiac resynchronisation therapy devices causing an adverse effect on patients

Due to a battery issue, medical equipment like implantable cardioverter defibrillators (ICD) and cardiac resynchronisation therapy devices (CRT-D) have reportedly failed, leading to serious concerns for patient health.

It’s thought that around 350,000 devices worldwide have been implanted and potentially put patient health at risk.
Continue Reading…

drugs
November 25, 2016
“Drugs that can give you mood swings” – Reports suggest that beta-blockers and calcium antagonists are medications that can lead to hospitalised mood disorders

Recent reports indicate that individuals taking medication known as beta-blockers and calcium antagonists for a period of more than 90 days may be susceptible to mood disorders that require hospital treatment.

These medications – commonly used to control blood pressure – are said to be a possible cause for major depression and / or bipolar disorder, drawn from comparisons with patients controlling their high blood pressure with angiotensin receptor blockers (ARBs) instead.
Continue Reading…

drugs
November 17, 2016
“Progestogen-only Pill Drug Recalls” – Teva UK Ltd has recalled drugs due to impurities showing in their routine testing

Teva UK Limited are one of the latest pharmaceutical manufacturers that have recalled a batch of their drugs.

The Nacrez 75 mg film-coated tablets have been recalled due to impurities found as part of their routine testing. The recall is said to be a precautionary measure taken by the company to ensure the safety of their customers.

However, as with any medicine recall, the dangers to human health are always something to closely monitor.
Continue Reading…

November 14, 2016
“The Deadly Stockert 3T Machine” – LivaNova machines that have allegedly caused dozens of patients to develop a mycobacterial infection

There are growing concerns surrounding the use of a particular type of heater-cooler system, Stockert 3T, manufactured by LivaNova, which are machines used during a patient’s surgery that have allegedly led to a spate of infections.

This was reportedly the case for Kenneth Piechowski, a Philadelphia man, when he had a surgery to replace a faulty aortic valve back in December 2014.
Continue Reading…

November 10, 2016
Tracheoesophageal voice devices are thought to only last three months

Tracheoesophageal voice devices have been reported to have a smaller life span than first anticipated.

What was thought to be at least a six month life span recently turned out to be only three months. This is a cause for concern as it could cause greater healthcare costs and a burden for the users who need to keep replacing them.
Continue Reading…

medical alert
August 30, 2016
Accu-Chek Insight insulin pump system prone to insulin leaks – risk of hyperglycaemia

A Medical Device Alert has been issued with the Medicines and Healthcare products Regulatory Agency (MHRA) for the Accu-Chek Insight insulin pump system using NovoRapid PumpCart cartridges which is reportedly prone to leakage.

Leakage of the devices, manufactured by Roche Diabetes Care, could lead to serious consequences for users, which could include hyperglycaemia, diabetic ketoacidosis, or even death.
Continue Reading…